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reports of detrimental effect, the majority of responding
transplant centers continue its use. Furthermore, timing for
initiating GCSF varied from D0 to D+12 in those centers.Table 1
Institution # Cords RIC/nonmyeloablative
BM/PBSC
Myeloablative
BM/PBSC
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3 D+7 D+7 D+7
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7 Not used Not used Not used
8 D0 D+5 D0
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+^*# indicates collaborationIn the current environment of reducing healthcare
costs, these ﬁndings suggest the need for reevaluation of
its use.
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Research regarding the promotion of evidence based
medicine (EBM) suggests that a common barrier to the
transition from knowledge acquisition to implementation
may be a lack of acceptance from other members of the
multidisciplinary healthcare team. A needs assessment
conducted on our Pediatric Blood and Marrow Trans-
plantation (PBMT) unit suggested that a journal club
would be an effective method to promote EBM. A multi-
disciplinary journal club (MJC) was introduced to: (i)
promote new, valid and relevant evidence into the clinical
pipeline; (ii) reduce barriers to implementation of new
innovations associated with lack of multidisciplinary
collaboration; (iii) foster multidisciplinary communication;
(iv) generate new ideas for research; (v) promote
EBM. Each month, 3 presenters discussed articles related
to their individual scope of practice, related to PBMT.
Articles were screened for relevance, innovation and
validity by members of a MJC committee. Attendees/
presenters included PBMT team members and members
of healthcare teams which frequently interact with PBMT.
A group discussion followed each presentation with
regard to relevance, applicability and implementation of
innovations presented. A survey was conducted after 7
consecutive MJCs to determine its impact. Characteristics
of attendees (n¼53) and presenters (n¼19) are shown in
Table 1. 100% of PBMT physicians, hospitalists, social
workers, nurse practitioners and child life specialists and
50% PBMT nurses attended more than one MJC. Results of
the impact survey demonstrated that 90% of respondents
(n¼21) “thought the articles presented were relevant to
their clinical practice.” 67% reported that they gained new
insights by attending MJC and could identify speciﬁc ways
to apply concepts discussed. At least six innovations were
implemented (changes in practice [n¼3] and multidisci-
plinary research proposals [n¼3]) over seven months, asa direct result of articles presented at MJC (Table 1). Most
successfully implemented innovations involved collabora-
tion between multidisciplinary team members.
Promotion of EBM can be achieved by a multidisciplinary
approach. A MJC allows for rapid implementation of
innovation by promoting more simultaneous acceptance
from all members of the multidisciplinary healthcare
team.515
Moving Practice Forward: Standardization of Infusion
Times for Hematopoietic Cells Utilizing an IV Pump
Theresa Latchford. Nursing, Stanford Hospital and Clinics, Los
Gatos, CA
Signiﬁcance: BMT recipients have a 12F central venous
catheter (CVC) placed prior to transplant to accommodate
hydration, medications, and blood testing. This catheter is
also required to ensure rapid infusion of hematopoietic cell
products via gravity. Variation of cell product infusion times
exists during gravity infusions related to patient symptoms,
patency of the CVC, rate at which the nurse infuses the
product, types of cells infused. Standardizing the cell
product infusion time utilizing an IV pump eliminates
variation and provides both the nurse and patient with
a better experience.
Purpose: The main purpose was to determine if hemato-
poietic cells infused via IV infusion pump over a set period of
time provided patients with less symptoms than gravity
infusions and nurses with a more efﬁcient way of delivering
cells.
Interventions: Practices of hematopoietic cell infusions at
other transplant centers were assessed. Cell viability of cry-
opreserved cell products after utilizing an IV pump for
infusion was determined. Samples of frozen products were
infused via IV infusion pump to determine cell viability post
infusion. A new procedure was written to infuse
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standardized infusion times. A symptom assessment survey
was completed by patients for comparing gravity infusions
with infusions via the IV pump. Nurses were survey
regarding this change in practice.
Evaluation: Patient symptoms were rated for cryopreserved
cell infusion prior to and after the initiation of a standardized
infusion time of 10 minutes. Nurses were asked to rate the
efﬁciency of utilizing an IV pump compared to gravity infu-
sion. Patients who entered the program with a previous
placed catheter that was not a 12F CVC were tracked to
determine a potential cost beneﬁt.
Discussion: By utilizing standardized infusion times and an
IV pump both nurses and patients have a better experience
with cell infusions.516
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One of the most rewarding parts of caring for the blood
and marrow transplant (BMT) patient is the long term rela-
tionships we build with them. Patients are often hospitalized
for extended periods of time and with the primary nursing
model, nurses have the opportunity to really get to know
their patients. For all of the rewards and beneﬁts this brings,
it also has inherent risks. The risk of drift from standards of
practice is notable due to our comfort level and familiarity
with patients and protocols. In addition, blood and marrow
transplant patients typically receive common medication
regimens, including antibiotics and immunosuppressive
agents. One look at the medication area for a BMT unit
reveals that most patients are receiving similar, if not the
same medications.
The journey towards a ‘Just Culture’ in our hospital has
successfully encouraged the use of the Self-Reporting
System when a medication error or near miss occurs, and
the BMT unit has consistently been recognized as a high-
reporting unit. The Oncology Safety Oversight Committee
conducted a three year retrospective analysis for speciﬁc
medication errors and an increase in the number of medi-
cation errors related to patient identiﬁcation was noted. The
BMT unit accounted for a total of 15 events reported, which
was 48% of all the errors of this type reported in Oncology. A
review of the literature suggested a link of this type of error
to ‘conﬁrmation bias’ which is when we see what is ex-
pected rather than what is there. A Failure Mode and Effect
Analysis was performed and the opportunity for conﬁrma-
tion bias was identiﬁed. Changes to a process such as
medication administration that disrupts the typical ﬂow
and thought process can reduce the tendency for the
conﬁrmation bias factor and the related potential errors. A
60 day trial was conducted where the fourth character of
the patient's medical record number on the IV bag label had
to be struck through by the nurse as part of the medication
administration “6 Rights.” This would potentially disrupt
the tendency to look at the number for conﬁrmation of the
expected medical record number. Staff feedback and
ongoing error rates were recorded to assess the effective-
ness of the trial.
As with many practice changes, unit leadership found
the need to reinforce communication of the practice changeand perform ongoing audits to ensure compliance. During
the 60 day trial, no patient identiﬁcation errors were re-
ported. Staff, given the choice, voted to incorporate the
practice into the unit's standard procedure for medication
administration. Since initiation of the strike through
process 18 months ago; only one event has been reported
and the practice has become part of the unit culture. The
practice has also been benchmarked by other units in the
hospital.517
A Paradigm Shift in Hematopoietic Progenitor Cell
Apheresis: From Apheresis Technicians to Trained
Oncology Nurses - Improving Patient Outcomes
Mary Mackrell 1, Maria Lopez-Bover 1, Judith Luck 1,
Monika Magnum1, Ana Leyva 1, Vera Santos Bachelor 2,
Lyle Feinstein 3. 1 BMT Program, Memorial Hospital West,
Pembroke Pines, FL; 2 Cancer Center - Bone Marrow Transplant,
Memorial Healthcare System, Pembroke Pines, FL; 3Memorial
Cancer Institute, Pembroke Pines, FL
Purpose and Background: According to published guide-
lines from FACT, apheresis must be performed by “adequately
trained” collection personnel. This recommendation gives
collection facilities wide latitude to determine the appro-
priate skill set for optimal apheresis collections. Comparing
apheresis-trained oncology nurses with apheresis techni-
cians, our program determined which group was best suited
for the early recognition and treatment of procedure-related
adverse reactions based on patient outcomes.
Upon the initiation of our community-based blood and
marrow transplant (BMT) program in 2007, the collection of
hematopoietic progenitor cells was contracted to a local
blood center. There were 35 collections performed on 12
patients using the contracted apheresis technicians on site.
Seventy-ﬁve percent (75%) of patients experienced apheresis
complications requiring immediate medical attention.
Interventions: To improve the quality outcomes within our
BMT program, a comprehensive nursing education plan was
developed and implemented in November 2008. A core
group of oncology nurses completed a competency-based
apheresis program. Protocols were developed for the nurse
to manage pre-emptive medical interventions when
required. Subsequent to this intervention, we used these
nursing personnel exclusively for collections.
Outcome: As of 2011, there have been 96 collections on 40
patients since switching to apheresis-trained nursing
personnel. With this change only 7.5% of the patients expe-
rienced adverse reactions, a ten-fold decrease. Although not
quantiﬁed, program staff felt there was additional improve-
ment to the quality of patient care; as therewas a decrease in
delays to addressing adverse reactions. The shift from tech-
nicians to apheresis trained oncology nurses was a timely
nursing intervention which improved patient outcomes by
an order of magnitude.518
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